Life Sciences Industry Win in China
A leading provider of genomic sequencing and proteomic services was having difficulty obtaining sufficient capacity to cover new COVID-19 related offerings. Our team in China quickly leveraged our life science industry knowledge and network to provide coverage and increase capacity.
“Marsh always maintains a keen understanding of our directions and strategies. Thanks to Marsh‘s professional risk solution, we have together achieved a meaningful outcome that will help in the global efforts against the COVID – 19 pandemic.”
Click on the infographic to learn more.